The inflammatory bowel diseases ulcerative colitis and Crohn's disease are chronic,
relapsing disorders of the gastrointestinal tract. Collectively, these conditions can result in …

The prevalence of inflammatory bowel disease, that is Crohn's disease and ulcerative colitis,
has increased over two to three generations in high-income countries, but in only one …

Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the
gastrointestinal tract with extraintestinal manifestations and associated immune disorders …

The UK and China provide unique historical perspectives on the evolution of the incidence
of inflammatory bowel disease, which might provide insight into its pathogenesis. Historical …

Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract, with
increasing incidence worldwide. Crohn's disease might result from a complex interplay …

The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase
worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease …

Inflammatory bowel disease (IBD) is increasing in prevalence in resource-limited settings in
Asia. Although the prevalence of IBD is lower in these settings than in high-income …

1 Ungaro RC, Brenner EJ, Gearry RB, et al. Effect of IBD medications on COVID-19
outcomes: results from an international registry. Gut 2020; published online Oct 20 …

It is probably wise to begin with the epidemiological data, since these are easiest to verify
and likely to be the most reliable. Three incontrovertible statements can be made: ulcerative …

Treatment strategies for inflammatory bowel disease (IBD) focus on the induction and long-
term maintenance of deep remission to avoid complications of active disease and improve …